Perioperative management of the patient with a coronary stent

Current Opinion in Anaesthesiology

Volumn 23, Issue 1, 2010, Pages 109-115

  Popescu, Wanda M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary stents; Dual antiplatelet therapy; Perioperative period

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; EFFIENT; EPTIFIBATIDE; PRASUGREL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TIROFIBAN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; BLEEDING; CORONARY ARTERY DISEASE; CORONARY STENT; DECISION MAKING; DRUG ELUTING STENT; DRUG MEGADOSE; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HIGH RISK PATIENT; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MORBIDITY; MORTALITY; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REGIONAL ANESTHESIA; REVIEW; STENT THROMBOSIS; THROMBECTOMY; TREATMENT WITHDRAWAL;

ALGORITHMS; ASPIRIN; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; TICLOPIDINE; TIME FACTORS;

EID: 75149144850     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283340b1a     Document Type: Review

References (42)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics: 2009 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:e21-e181.
2. Newsome LT, Weller RS, Gerancher JC, et al. Coronary artery stents: II. Perioperative considerations and management. Anesth Analg 2008; 107:570-590.
3. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301:61-68. (Pubitemid 9229695)
4. Metzler H, Kozek-Langenecker S, Huber K. Antiplatelet therapy and coronary stents in perioperative medicine: the two sides of the coin. Best Pract Res Clin Anaesthesiol 2008; 22:81-94.
5. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med 2006; 354:483-495.
6. Arjomand H, Turi ZG, McCormick D, et al. Percutaneous coronary intervention: historical perspectives, current status, and future directions. Am Heart J 2003; 146:787-796.
7. Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian metaanalysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364:583-591.
8. SPIRIT V. A clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions. EuroPCR; Barcelona, Spain; 2009.
9. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130.
10. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drugeluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356:1009-1019.
11. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109:701-705.
12. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45:947-953.
13. Urban P, Gershlick AH, Guagliumi G, et al. Safety of coronary sirolimuseluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 2006; 113:1434-1441.
14. Rodriguez AE, Mieres J, Fernandez-Pereira C, et al. Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. J Am Coll Cardiol 2006; 47:205-207.
15. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. J Am Coll Cardiol 2006; 47:2112-2115.
16. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297:159-168.
17. Laskey WK, Yancy CW, Maisel WH. Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006. Circulation 2007; 115:2352-2357.
18. Win HK, Caldera AE, Maresh K, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297:2001-2009.
19. Godet G, Le Manach Y, Lesache F, et al. Drug-eluting stent thrombosis in patients undergoing noncardiac surgery: is it always a problem? Br J Anaesth 2008; 100:472-477. (Pubitemid 351773621)
20. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115:813-818.
21. Iakovou I, Agostini P, Biondi-Zoccai G, et al. A simple risk score for prediction of thrombosis after drug-eluting stent implantation (abstract #3749). European Society of Cardiology Congress; 03-07 September 2005; Stockholm, Sweden; 2005.
22. Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008; 299:532-539.
23. Nuttall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109:588-595.
24. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109:596-604.
25. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804.
26. Poldermans D, Schouten O, Vidakovic R, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007; 49:1763-1769.
27. Practice alert for the perioperative management of patients with coronary artery stents: a report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2009; 110:22-23.
28. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007; 50:e159-241.
29. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006; 99:1293-1304.
30. Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res 2007; 100:1261-1275.
31. Bhatt DL. Prasugrel in clinical practice. N Engl J Med 2009; 361:940-942.
32. Banerjee S, Varghese C, Samuel J, et al. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality. Am J Cardiol 2008; 102:1159-1162.
33. Eikelboom JW, Hirsh J. Bleeding and management of bleeding. Eur Heart J 2006; 8 (Suppl. G):G38-G45.
34. Jolly SS, Pogue J, Haladyn K, et al. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCICURE study. Eur Heart J 2009; 30:900-907.
35. Dalal AR, D'Souza S, Shulman MS. Brief review: coronary drug-eluting stents and anesthesia. Can J Anaesth 2006; 53:1230-1243.
36. Augoustides JG. Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade. Anesthesiology 2007; 107:516.
37. Broad L, Lee T, Conroy M, et al. Successful management of patients with a drug-eluting coronary stent presenting for elective, noncardiac surgery. Br J Anaesth 2007; 98:19-22.
38. Moen MD, Keating GM, Wellington K. Bivalirudin: a review of its use in patients undergoing percutaneous coronary intervention. Drugs 2005; 65:1869-1891.
39. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007; 49:2145-2150.
40. Douketis JD, Dentali F. Managing anticoagulant and antiplatelet drugs in patients who are receiving neuraxial anesthesia and epidural analgesia: a practical guide for clinicians. Tech Reg Anesth Pain Manage 2006; 10: 46-55.
41. Popescu WM, Gusberg RJ, Barash PG. Epidural catheters and drug-eluting stents: a challenging relationship. J Cardiothorac Vasc Anesth 2007; 21:701-703.
42. Mauermann WJ, Rehfeldt KH, Bell MR, et al. Percutaneous coronary interventions and antiplatelet therapy in the perioperative period. J Cardiothorac Vasc Anesth 2007; 21:436-442.